Prof. Dr. Mike (Przemlysaw) Sapieha, an expert in translational eye research at the University of Montreal in Canada, visited the FOR2240 research group and the Chair of Experimental Immunology of the Eye at the Center for Ophthalmology of the University Hospital Cologne and the Faculty of Medicine at the end of March. For several years, there has been a close research collaboration on the role of the immune system in age-related macular degeneration (AMD), the most common cause of vision loss in older age.

The European Union has supported a research proposal on new therapies to restore visual acuity in rare and severe ocular surface diseases under the Horizon Health program. The RESTORE VISION consortium, consisting of the Universities of Cologne, Galway, Milan, Linjöping and Paris, and four industrial partners, has received a total of eight million euros in funding over four years.

The Experimental Glaucoma Research Group at the Department of Ophthalmology of the University Hospital of Cologne and the Faculty of Medicine, headed by Univ.- Prof. Dr. Verena Prokosch, has received funding and awards.